Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Non-cash Items (2010 - 2016)

Grifols' (GIFLF) quarterly Non-cash Items came in at $108.1 million in Q4 2016, down 18.04% on a YoY basis from $131.9 million in Q1 2016, and up 9.57% quarter-over-quarter from $98.7 million in Q3 2016.

Analysis

Grifols (GIFLF) Non-cash Items (2010 - 2016) Analysis & Trends

Grifols (GIFLF) has reported Non-cash Items for 7 consecutive years, with $108.1 million the latest figure, recorded in Q4 2016.

  • For the quarter ending Q4 2016, Non-cash Items fell 18.04% year-over-year to $108.1 million; the trailing twelve-month figure through Dec 2016 stood at $480.1 million (down 6.07% YoY), and the FY2025 full-year result was $1.3 billion, up 2.69% from the prior year.
  • Non-cash Items improved to $108.1 million in Q4 2016 per GIFLF's latest filing, from $98.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $511.6 million in Q3 2014 and bottomed at -$156.6 million in Q2 2014.
  • Historically, Non-cash Items has averaged $130.6 million across 5 years, with a median of $122.3 million in 2012.
  • The sharpest annual moves came in 2012 and 2014: Non-cash Items surged 556.04% in 2012, then tumbled 236.46% in 2014.
  • Over 5 years, Non-cash Items stood at $150.9 million in 2012, then decreased by 29.88% to $105.8 million in 2013, then jumped by 36.46% to $144.4 million in 2014, then dropped by 8.64% to $131.9 million in 2015, then decreased by 18.04% to $108.1 million in 2016.
  • According to Business Quant data, Non-cash Items over the past three periods registered $108.1 million, $98.7 million, and $131.9 million for Q4 2016, Q3 2016, and Q4 2015 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 108.12 Mn
Sep 30, 2016 98.68 Mn
Dec 31, 2015 131.92 Mn
Sep 30, 2015 141.38 Mn
Jun 30, 2015 131.67 Mn
Mar 31, 2015 106.15 Mn
Dec 31, 2014 144.40 Mn
Sep 30, 2014 511.64 Mn
Jun 30, 2014 -156.60 Mn
Mar 31, 2014 156.73 Mn
Dec 31, 2013 105.82 Mn
Sep 30, 2013 109.37 Mn
Jun 30, 2013 114.76 Mn
Mar 31, 2013 131.61 Mn
Dec 31, 2012 150.91 Mn
Sep 30, 2012 120.17 Mn
Jun 30, 2012 120.92 Mn
Mar 31, 2012 123.78 Mn
Dec 31, 2011 188.03 Mn
Sep 30, 2011 115.66 Mn